Belize vs Suriname: Share of the population living with HIV receiving antiretroviral therapy
Belize
49.6%
in 2024
Suriname
49.1%
in 2024
Belize rank
127th
Suriname rank
128th
Share of the population living with HIV receiving antiretroviral therapy over time
- Belize
- Suriname
How they compare
Belize currently reports 49.6% against 49.1% in Suriname, a difference of 0.5%.
The two have swapped places 9 times across 35 shared years of data; in 1990 it was Suriname ahead.
Belize ranks 127th and Suriname ranks 128th of 149 countries.
Across the 4 decades both report, Belize averaged higher in 2 and Suriname in 1.
Head to head by decade
| Decade | Belize | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 10.0% | 7.3% | 2.8% | Belize |
| 2010s | 34.9% | 33.2% | 1.7% | Belize |
| 2020s | 44.8% | 46.3% | 1.5% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Belize or Suriname?
- Belize, at 49.6% against 49.1% in Suriname as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Belize and Suriname?
- 0.5%, with Belize ahead.
- How many years of comparable data are there for Belize and Suriname?
- 35 years are reported by both, from 1990 to 2024.
- How do Belize and Suriname rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Belize ranks 127th and Suriname ranks 128th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.